A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia

Completed · Phase 1/Phase 2

Conditions studied: Cervical Intraepithelial Neoplasia

In brief

The primary objective of this study is to determine pilot safety and efficacy data for a topical formulation of EM-1421 applied to the cervix of patients with CIN 1, 2, or 3.

Key facts

Study ID

NCT00154089

Run by

Erimos Pharmaceuticals

People needed

8

Starts

2004-11-01

Expected to finish

2006-12-01

Last updated by the study team

2016-02-23

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Negative pregnancy test
• Biopsy confirmed CIN 1, 2, or 3

You may not qualify if…

• Pregnancy or breast feeding

Where it is running

• University of Maryland, Dept. of Family Medicine — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.